Palmoplantar pustulosis - I-Palmoplantar Pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
I- I-Palmoplantar Pustulosis (Palmoplantar pustulosis) i-pustular dermatosis engapheli (okungukuthi, i-pustulosis noma i-pustular psoriasis) etholakala ezintendeni zezandla nasematheni kuphela, ebonakala nge-histologically ngama-intraepidermal pustules agcwele ama-neutrophils. Ukusetshenziswa kwe-systemic retinoids iyodwa futhi kuhlanganiswe ne-photochemotherapy ukuze kuthuthukiswe izimpawu ze- i-palmoplantar pustulosis (palmoplantar pustulosis) .

○ Ukwelashwa
I-oral acitretin iyasebenza kulolu hlobo lwe-psoriasis.
#Acitretin
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
  • Kulokhu, i-pompholyx nayo ingasoleka.
  • Uma engekho ama-pustules, i-eczema yesandla nayo ingabhekwa njengokuxilongwa okuhlukile.
References Palmoplantar Psoriasis 28846363 
NIH
I- Palmoplantar psoriasis wuhlobo lwe-psoriasis oluthinta kakhulu isikhumba ezintendeni zezandla nasematheni akho. Ibonakala njengesikhumba esijiyile esomile, esinamabhamuza, noma inhlanganisela yazo zombili izinhlobo.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).